Cite

HARVARD Citation

    Cho, D. et al. (n.d.). Resveratrol and ivacaftor are additive G551D CFTR‐channel potentiators: therapeutic implications for cystic fibrosis sinus disease. International forum of allergy & rhinology. 9 (1), pp. 100-105. [Online]. 
  
Back to record